This inventor holds 1 USPTO granted patent. Top assignee: Incyte Corporation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Genfeng Cao: Innovator in Chemokine Receptor Antagonists
Introduction
Genfeng Cao is a notable inventor based in Bear, Delaware, who has made significant contributions to the field of medicinal chemistry. His work primarily focuses on developing compounds that target chemokine receptors, which play a crucial role in various diseases.
Latest Patents
Genfeng Cao holds a patent for "Piperazinylpiperidine derivatives as chemokine receptor antagonists." This invention relates to compounds that modulate the activity of or bind to chemokine receptors such as CCR5. The compounds are designed to be selective for CCR5 and can be utilized in treating diseases associated with chemokine receptor expression or activity, including inflammatory diseases, immune diseases, and viral infections. He has 1 patent to his name.
Career Highlights
Cao is currently employed at Incyte Corporation, where he continues to advance his research in the pharmaceutical industry. His innovative work has the potential to lead to new therapeutic options for patients suffering from various conditions.
Collaborations
Throughout his career, Genfeng Cao has collaborated with esteemed colleagues, including Chu-Biao Xue and Taisheng Huang. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.
Conclusion
Genfeng Cao's contributions to the field of chemokine receptor antagonists highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile